Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kreutz

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Annals of the Rheumatic Diseases|October 16, 2002
Weight and consequences of post-marketing (-approval) experienceG Kreutz
Annals of the Rheumatic Diseases|December 1, 1999
European regulatory aspects on new medicines targeted at treatment of rheumatoid arthritisG Kreutz
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 12, 2005
[Clinical trials for medicinal products. New European and national legal rules]G Kreutz
Zeitschrift Fur Urologie Und Nephrologie|February 1, 1980
[Quantitative DNCB reaction in patients with hypernephroma]G Kreutz, K Bandhauer
Helvetica Chirurgica Acta|June 1, 1977
[Evaluation of urethral injuries in patients with multile injuries]G Kreutz, K Bandhauer
Annals of the Rheumatic Diseases|October 29, 2000
Which post-marketing database and studies does EMEA requireG Kreutz, L Heng
Helvetica Chirurgica Acta|August 1, 1979
[Incidence of adrenal metastasis from renal carcinoma]G Kreutz, R Habegger
Deutsche Medizinische Wochenschrift (1946)|May 9, 1980
[No quinidine interaction with digitoxin]F Keller, G Kreutz
Journal of Chromatography|May 14, 1982
Quantitative thin-layer chromatographic determination of dihydroergot alkaloidsE Riedel, G Kreutz, D Hermsdorf
Revue Des Maladies Respiratoires|June 6, 2007
[Contribution of psychomotricity in respiratory rehabilitation programs]M Aumignon, G Kreutz, K Beauchet, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|October 16, 2002
Weight and consequences of post-marketing (-approval) experienceG Kreutz
Annals of the Rheumatic Diseases|December 1, 1999
European regulatory aspects on new medicines targeted at treatment of rheumatoid arthritisG Kreutz
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 12, 2005
[Clinical trials for medicinal products. New European and national legal rules]G Kreutz
Zeitschrift Fur Urologie Und Nephrologie|February 1, 1980
[Quantitative DNCB reaction in patients with hypernephroma]G Kreutz, K Bandhauer
Helvetica Chirurgica Acta|June 1, 1977
[Evaluation of urethral injuries in patients with multile injuries]G Kreutz, K Bandhauer
Annals of the Rheumatic Diseases|October 29, 2000
Which post-marketing database and studies does EMEA requireG Kreutz, L Heng
Helvetica Chirurgica Acta|August 1, 1979
[Incidence of adrenal metastasis from renal carcinoma]G Kreutz, R Habegger
Deutsche Medizinische Wochenschrift (1946)|May 9, 1980
[No quinidine interaction with digitoxin]F Keller, G Kreutz
Journal of Chromatography|May 14, 1982
Quantitative thin-layer chromatographic determination of dihydroergot alkaloidsE Riedel, G Kreutz, D Hermsdorf
Revue Des Maladies Respiratoires|June 6, 2007
[Contribution of psychomotricity in respiratory rehabilitation programs]M Aumignon, G Kreutz, K Beauchet, et al.
Pageof 3